跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pointfixime - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pointfixime
Approved
STANDARD
Pointfixime
Akums Drugs Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cf3c7f3a28f9d1ff
Company
Akums Drugs Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)
Type
Standard
Approval Details
Approval Id
cf3c7f3a28f9d1ff
Drug Approval Philippines Name
Pointfixime
Product Name
Pointfixime
Registration Number
DRP-2654-07
Brand Name
Pointfixime
Generic Name
Cefixime (As Trihydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
200 mg
Manufacturer
Akums Drugs Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)
Trader
Unosource Pharma Ltd.
Importer
Ambica International Corporation
Distributor
Westpoint Pharma Inc.
Issuance Date
25 July 2023
Expiry Date
20 December 2028
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cf3c7f3a28f9d1ff
Type
Standard
Back to Philippines FDA Approvals